Glycogen Storage Disease Type II Infantile Onset Clinical Trials in Salt Lake City, Utah

A Study to Evaluate the Safety, Efficacy, PK, PD and Immunogenicity of Cipaglucosidase Alfa/Miglustat in IOPD Subjects Aged 0 to <18